Shanghai, China · Founded 2021 · Privately Held (backing)
Developer of in vivo gene editing therapies focusing on serious diseases using lipid nanoparticle delivery systems. YolTech Therapeutics is based in Shanghai, China and was founded in 2021. Its last reported valuation was $136 million in Sep 2023. It has raised $75.1 million.
Last reported valuation
$135.8M
Oct 2026
Priced at
—
Total raised
$75.1M
Last round
—
Team — not yet on record
No current team members for YolTech Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of YolTech Therapeutics with a free account
·The complete investor list: 14 names
·Watch YolTech Therapeutics: the Monday email on marks, rounds and moves
